Community Bank & Trust Waco Texas Has $626,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH)

Community Bank & Trust Waco Texas trimmed its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 5.7% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,801 shares of the medical equipment provider’s stock after selling 350 shares during the period. Community Bank & Trust Waco Texas’ holdings in Zimmer Biomet were worth $626,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Missouri Trust & Investment Co increased its position in Zimmer Biomet by 2.6% during the third quarter. Missouri Trust & Investment Co now owns 12,035 shares of the medical equipment provider’s stock worth $1,299,000 after buying an additional 303 shares during the last quarter. Versor Investments LP raised its stake in Zimmer Biomet by 93.4% during the 3rd quarter. Versor Investments LP now owns 18,565 shares of the medical equipment provider’s stock valued at $2,004,000 after purchasing an additional 8,965 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Zimmer Biomet in the third quarter valued at about $28,000. River Global Investors LLP increased its position in shares of Zimmer Biomet by 31.3% during the third quarter. River Global Investors LLP now owns 21,084 shares of the medical equipment provider’s stock valued at $2,276,000 after purchasing an additional 5,030 shares during the period. Finally, Covestor Ltd raised its stake in shares of Zimmer Biomet by 36.3% in the 3rd quarter. Covestor Ltd now owns 1,088 shares of the medical equipment provider’s stock valued at $117,000 after buying an additional 290 shares in the last quarter. Institutional investors and hedge funds own 88.89% of the company’s stock.

Analyst Ratings Changes

A number of research firms have weighed in on ZBH. UBS Group decreased their price objective on Zimmer Biomet from $112.00 to $107.00 and set a “sell” rating on the stock in a report on Thursday, August 8th. Wolfe Research began coverage on shares of Zimmer Biomet in a report on Tuesday, September 10th. They issued a “peer perform” rating on the stock. Needham & Company LLC restated a “hold” rating on shares of Zimmer Biomet in a research report on Thursday, October 31st. Raymond James cut their target price on shares of Zimmer Biomet from $128.00 to $123.00 and set an “outperform” rating for the company in a research note on Monday, October 14th. Finally, TD Cowen decreased their price target on Zimmer Biomet from $143.00 to $119.00 and set a “hold” rating on the stock in a research report on Friday, September 6th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Zimmer Biomet has an average rating of “Hold” and an average target price of $124.11.

Zimmer Biomet Trading Up 0.4 %

ZBH opened at $109.95 on Wednesday. The firm’s fifty day moving average is $106.26 and its two-hundred day moving average is $110.25. The firm has a market cap of $21.89 billion, a PE ratio of 20.90, a price-to-earnings-growth ratio of 2.01 and a beta of 1.02. Zimmer Biomet Holdings, Inc. has a twelve month low of $101.47 and a twelve month high of $133.90. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.70 and a current ratio of 1.36.

Zimmer Biomet (NYSE:ZBH) last posted its earnings results on Wednesday, October 30th. The medical equipment provider reported $1.74 earnings per share for the quarter, hitting the consensus estimate of $1.74. Zimmer Biomet had a return on equity of 12.95% and a net margin of 14.27%. The firm had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the company posted $1.65 earnings per share. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. Equities research analysts anticipate that Zimmer Biomet Holdings, Inc. will post 7.99 EPS for the current year.

Zimmer Biomet Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Monday, September 30th were paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 0.87%. The ex-dividend date was Monday, September 30th. Zimmer Biomet’s payout ratio is presently 18.25%.

Zimmer Biomet Company Profile

Zimmer Biomet Holdings, Inc, together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.